Prospective randomized study ARMYDA PRIME

Trial Profile

Prospective randomized study ARMYDA PRIME

Phase of Trial: Phase IV

Latest Information Update: 11 Mar 2014

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Myocardial infarction; Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top